Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1995 Mar;63(3):1127–1129. doi: 10.1128/iai.63.3.1127-1129.1995

Expression of a nonagglutinating fimbria by Proteus mirabilis.

D L Tolson 1, D L Barrigar 1, R J McLean 1, E Altman 1
PMCID: PMC173121  PMID: 7868237

Abstract

We have clarified growth conditions and isolation strategies for the nonagglutinating fimbriae from Proteus mirabilis. Nonagglutinating fimbriae were expressed by all P. mirabilis strains we examined, and the major subunit proteins, which ranged from 23 to 29 kDa as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, had highly conserved N-terminal sequences.

Full Text

The Full Text of this article is available as a PDF (196.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adegbola R. A., Old D. C., Senior B. W. The adhesins and fimbriae of Proteus mirabilis strains associated with high and low affinity for the urinary tract. J Med Microbiol. 1983 Nov;16(4):427–431. doi: 10.1099/00222615-16-4-427. [DOI] [PubMed] [Google Scholar]
  2. Allison C., Coleman N., Jones P. L., Hughes C. Ability of Proteus mirabilis to invade human urothelial cells is coupled to motility and swarming differentiation. Infect Immun. 1992 Nov;60(11):4740–4746. doi: 10.1128/iai.60.11.4740-4746.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bahrani F. K., Cook S., Hull R. A., Massad G., Mobley H. L. Proteus mirabilis fimbriae: N-terminal amino acid sequence of a major fimbrial subunit and nucleotide sequences of the genes from two strains. Infect Immun. 1993 Mar;61(3):884–891. doi: 10.1128/iai.61.3.884-891.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bahrani F. K., Johnson D. E., Robbins D., Mobley H. L. Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection. Infect Immun. 1991 Oct;59(10):3574–3580. doi: 10.1128/iai.59.10.3574-3580.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bahrani F. K., Massad G., Lockatell C. V., Johnson D. E., Russell R. G., Warren J. W., Mobley H. L. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Infect Immun. 1994 Aug;62(8):3363–3371. doi: 10.1128/iai.62.8.3363-3371.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bahrani F. K., Mobley H. L. Proteus mirabilis MR/P fimbriae: molecular cloning, expression, and nucleotide sequence of the major fimbrial subunit gene. J Bacteriol. 1993 Jan;175(2):457–464. doi: 10.1128/jb.175.2.457-464.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eriksson S., Zbornik J., Dahnsjö H., Erlanson P., Kahlmeter O., Fritz H., Bauer C. A. The combination of pivampicillin and pivmecillinam versus pivampicillin alone in the treatment of acute pyelonephritis. Scand J Infect Dis. 1986;18(5):431–438. doi: 10.3109/00365548609032360. [DOI] [PubMed] [Google Scholar]
  8. Forney L. J., Marrs C. F., Bektesh S. L., Gilsdorf J. R. Comparison and analysis of the nucleotide sequences of pilin genes from Haemophilus influenzae type b strains Eagan and M43. Infect Immun. 1991 Jun;59(6):1991–1996. doi: 10.1128/iai.59.6.1991-1996.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fowler J. E., Jr, Stamey T. A. Studies of introital colonization in women with recurrent urinary infections. X. Adhesive properties of Escherichia coli and Proteus mirabilis: lack of correlation with urinary pathogenicity. J Urol. 1978 Sep;120(3):315–318. doi: 10.1016/s0022-5347(17)57152-9. [DOI] [PubMed] [Google Scholar]
  10. Griffith D. P., Musher D. M., Itin C. Urease. The primary cause of infection-induced urinary stones. Invest Urol. 1976 Mar;13(5):346–350. [PubMed] [Google Scholar]
  11. Hornick D. B., Allen B. L., Horn M. A., Clegg S. Fimbrial types among respiratory isolates belonging to the family Enterobacteriaceae. J Clin Microbiol. 1991 Sep;29(9):1795–1800. doi: 10.1128/jcm.29.9.1795-1800.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jones B. D., Lockatell C. V., Johnson D. E., Warren J. W., Mobley H. L. Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection. Infect Immun. 1990 Apr;58(4):1120–1123. doi: 10.1128/iai.58.4.1120-1123.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Koronakis V., Cross M., Senior B., Koronakis E., Hughes C. The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli. J Bacteriol. 1987 Apr;169(4):1509–1515. doi: 10.1128/jb.169.4.1509-1515.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lintermans P., Pohl P., Deboeck F., Bertels A., Schlicker C., Vandekerckhove J., Van Damme J., Van Montagu M., De Greve H. Isolation and nucleotide sequence of the F17-A gene encoding the structural protein of the F17 fimbriae in bovine enterotoxigenic Escherichia coli. Infect Immun. 1988 Jun;56(6):1475–1484. doi: 10.1128/iai.56.6.1475-1484.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Massad G., Bahrani F. K., Mobley H. L. Proteus mirabilis fimbriae: identification, isolation, and characterization of a new ambient-temperature fimbria. Infect Immun. 1994 May;62(5):1989–1994. doi: 10.1128/iai.62.5.1989-1994.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Massad G., Lockatell C. V., Johnson D. E., Mobley H. L. Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection. Infect Immun. 1994 Feb;62(2):536–542. doi: 10.1128/iai.62.2.536-542.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McLean R. J., Nickel J. C., Cheng K. J., Costerton J. W. The ecology and pathogenicity of urease-producing bacteria in the urinary tract. Crit Rev Microbiol. 1988;16(1):37–79. doi: 10.3109/10408418809104467. [DOI] [PubMed] [Google Scholar]
  18. Mobley H. L., Chippendale G. R. Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources. J Infect Dis. 1990 Mar;161(3):525–530. doi: 10.1093/infdis/161.3.525. [DOI] [PubMed] [Google Scholar]
  19. Mobley H. L., Chippendale G. R., Swihart K. G., Welch R. A. Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells. Infect Immun. 1991 Jun;59(6):2036–2042. doi: 10.1128/iai.59.6.2036-2042.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mobley H. L., Warren J. W. Urease-positive bacteriuria and obstruction of long-term urinary catheters. J Clin Microbiol. 1987 Nov;25(11):2216–2217. doi: 10.1128/jcm.25.11.2216-2217.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Old D. C., Adegbola R. A. Haemagglutinins and fimbriae of Morganella, Proteus and Providencia. J Med Microbiol. 1982 Nov;15(4):551–564. doi: 10.1099/00222615-15-4-551. [DOI] [PubMed] [Google Scholar]
  22. Pazin G. J., Braude A. I. Immobilizing antibodies in urine. II. Prevention of ascending spread of Proteus mirabilis. Invest Urol. 1974 Sep;12(2):129–133. [PubMed] [Google Scholar]
  23. Peerbooms P. G., Verweij A. M., MacLaren D. M. Vero cell invasiveness of Proteus mirabilis. Infect Immun. 1984 Mar;43(3):1068–1071. doi: 10.1128/iai.43.3.1068-1071.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Peerbooms P. G., Verweij A. M., Oe P. L., MacLaren D. M. Urinary pathogenicity of Proteus mirabilis strains isolated from faeces or urine. Antonie Van Leeuwenhoek. 1986;52(1):53–62. doi: 10.1007/BF00402687. [DOI] [PubMed] [Google Scholar]
  25. Sareneva T., Holthöfer H., Korhonen T. K. Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract. Infect Immun. 1990 Oct;58(10):3330–3336. doi: 10.1128/iai.58.10.3330-3336.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Setia U., Serventi I., Lorenz P. Bacteremia in a long-term care facility. Spectrum and mortality. Arch Intern Med. 1984 Aug;144(8):1633–1635. [PubMed] [Google Scholar]
  27. Silverblatt F. J. Host-parasite interaction in the rat renal pelvis: a possible role for pili in the pathogenesis of pyelonephritis. J Exp Med. 1974 Dec 1;140(6):1696–1711. doi: 10.1084/jem.140.6.1696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Taylor G. R., Kropp K. D., Molina T. C. Nine-year microflora study of an isolator-maintained immunodeficient child. Appl Environ Microbiol. 1985 Dec;50(6):1349–1356. doi: 10.1128/aem.50.6.1349-1356.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Watson D. C., Yaguchi M., Lynn K. R. The amino acid sequence of chymopapain from Carica papaya. Biochem J. 1990 Feb 15;266(1):75–81. doi: 10.1042/bj2660075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Welch R. A. Identification of two different hemolysin determinants in uropathogenic Proteus isolates. Infect Immun. 1987 Sep;55(9):2183–2190. doi: 10.1128/iai.55.9.2183-2190.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wray S. K., Hull S. I., Cook R. G., Barrish J., Hull R. A. Identification and characterization of a uroepithelial cell adhesin from a uropathogenic isolate of Proteus mirabilis. Infect Immun. 1986 Oct;54(1):43–49. doi: 10.1128/iai.54.1.43-49.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES